Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 569.00 | 443.75 | 1.2823 | 1.7440 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 379.00 | 443.75 | 0.8541 | 0.6364 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 312.50 | 257.33 | 279.00 | 443.75 | 0.6287 | 0.1083 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 312.50 | 257.33 | 398.00 | 443.75 | 0.8969 | 0.7415 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 312.50 | 257.33 | 391.00 | 443.75 | 0.8811 | 0.7026 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 312.50 | 257.33 | 392.00 | 443.75 | 0.8834 | 0.7082 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 312.50 | 257.33 | 315.00 | 443.75 | 0.7099 | 0.2933 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 312.50 | 257.33 | 167.00 | 443.75 | 0.3763 | -0.4231 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 411.00 | 443.75 | 0.9262 | 0.8142 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 308.00 | 443.75 | 0.6941 | 0.2569 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 858.00 | 970.00 | 0.8845 | 0.7158 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 893.00 | 970.00 | 0.9206 | 0.8037 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 625.00 | 556.96 | 1021.00 | 970.00 | 1.0526 | 1.1322 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1005.00 | 970.00 | 1.0361 | 1.0906 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 625.00 | 556.96 | 960.00 | 970.00 | 0.9897 | 0.9743 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 625.00 | 556.96 | 717.00 | 970.00 | 0.7392 | 0.3710 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1104.00 | 970.00 | 1.1381 | 1.3509 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1271.00 | 970.00 | 1.3103 | 1.8033 | |
| SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 625.00 | 556.96 | 1261.00 | 970.00 | 1.3000 | 1.7758 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 625.00 | 556.96 | 1183.00 | 970.00 | 1.2196 | 1.5630 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 625.00 | 556.96 | 544.00 | 970.00 | 0.5608 | -0.0290 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 625.00 | 556.96 | 1248.00 | 970.00 | 1.2866 | 1.7401 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 625.00 | 556.96 | 487.00 | 970.00 | 0.5021 | -0.1544 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 625.00 | 556.96 | 846.00 | 970.00 | 0.8722 | 0.6858 |
| SK-BR-3 | Taxol | 0.31623 | uM | 3 | 625.00 | 556.96 | 480.00 | 970.00 | 0.4949 | -0.1696 |